The ideal treatment for GD would be to target its pathogenic mechanisms by modulating the autoimmune process directed against the TSH receptor or by competing with thyroid-stimulating antibody. While waiting for novel therapeutic tools, the management of GD in its different grades of severity and complications still requires a careful clinical approach and biochemical evaluation aimed at an early discrimination between eventually relapsing and remitting patients after medical therapy. Last, but not least, all available treatment options and their outcomes should be discussed with the patient. This decision process will, in many ways, provide personalized treatment utilizing the best therapeutic tools currently available.
THE MEDICAL MANAGEMENT OF GRAVES DISEASE IN THE ERA OF PRECISION MEDICINE
Chiovato, Luca;Magri, Flavia
2019-01-01
Abstract
The ideal treatment for GD would be to target its pathogenic mechanisms by modulating the autoimmune process directed against the TSH receptor or by competing with thyroid-stimulating antibody. While waiting for novel therapeutic tools, the management of GD in its different grades of severity and complications still requires a careful clinical approach and biochemical evaluation aimed at an early discrimination between eventually relapsing and remitting patients after medical therapy. Last, but not least, all available treatment options and their outcomes should be discussed with the patient. This decision process will, in many ways, provide personalized treatment utilizing the best therapeutic tools currently available.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
